 BetterLife Pharma Inc CSE:BETR, OTCQB:BETRF has announced that its subsidiary, Altum Pharmaceuticals Inc has obtained non-dilutive financing from a key investor. The subsidiary has inked an agreement with a European investor group to purchase up to US5 million Altum shares by way of a non-brokered financing in tranches that will start in January 2022. 